Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laryngeal neoplasm
|
1 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Adult Solid Neoplasm
|
3 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Childhood Solid Neoplasm
|
3 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Laryngeal Diseases
|
7 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Extrapulmonary Small Cell Carcinoma
|
11 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Gastric Cardia Adenocarcinoma
|
11 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Solid Neoplasm
|
24 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Complete Trisomy 21 Syndrome
|
77 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Giant Cell Arteritis
|
78 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Down Syndrome
|
80 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Head and Neck Carcinoma
|
118 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Neural Tube Defects
|
122 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.030 | 1.000 | 3 | 2001 | 2017 | ||||
Childhood Leukemia
|
140 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
leukemia
|
144 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1 | 2014 | 2014 | |||||
Adult Acute Lymphocytic Leukemia
|
154 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.030 | 1.000 | 3 | 2002 | 2012 | ||||
Lymphoma, Non-Hodgkin
|
197 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2004 | 2015 | ||||
Adenoma of large intestine
|
213 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Acute lymphocytic leukemia
|
222 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||
Colon Carcinoma
|
275 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.620 | 0.560 | 17 | 18328782 | missense variant | G/A | snv | 0.27 | 0.31 | 0.010 | 1.000 | 1 | 2007 | 2007 |